Quidel (NASDAQ:QDEL – Get Rating) and Alpha Teknova (NASDAQ:TKNO – Get Rating) are both medical companies, but which company is better? We’ll compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends and institutional ownership.
This is a breakdown of recent recommendations for Quidel and Alpha Teknova, as provided by MarketBeat.com.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
Quidel currently has a consensus target price of $143.00, indicating a potential upside of 45.49%. Alpha Teknova has a consensus target price of $27.33, indicating an upside potential of 173.33%. Given Alpha Teknova’s likely higher upside, analysts clearly believe that Alpha Teknova is more favorable than Quidel.
This table compares the net margins, return on equity and return on assets of Quidel and Alpha Teknova.
|Net margins||Return on equity||return on assets|
|Alpha Teknova||N / A||N / A||N / A|
Insider and Institutional Ownership
92.9% of Quidel shares are held by institutional investors. By comparison, 25.5% of Alpha Teknova’s shares are held by institutional investors. 2.7% of Quidel’s stock is held by company insiders. Strong institutional ownership indicates that large money managers, endowments, and hedge funds believe a stock will outperform the market over the long term.
Benefits and evaluation
This table compares the revenue, earnings per share and valuation of Quidel and Alpha Teknova.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|Quidel||$1.70 billion||2.42||$704.23 million||$23.69||4.15|
|Alpha Teknova||$36.89 million||7.60||-9.80 million dollars||N / A||N / A|
Quidel has higher revenue and profit than Alpha Teknova.
Quidel beats Alpha Teknova on 9 out of 12 factors compared between the two stocks.
About Quidel (Get a rating)
Quidel Corporation develops, manufactures and markets diagnostic testing solutions for applications in infectious disease, cardiology, thyroid, women’s and general health, eye health, gastrointestinal disease and toxicology worldwide. It offers Sofia and Sofia 2 fluorescence immunoassay systems; QuickVue, a lateral flow immunoassay product; and InflammaDry and AdenoPlus, POC products for detecting infectious and inflammatory diseases and conditions of the eye. The Company also provides Triage MeterPro, a portable testing platform that enables physicians to promote better health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter laboratory analyzers; and Triage TOX Drug Screen, which provides results for the presence of drugs and/or major metabolites in urine. Additionally, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories growing and testing various human viruses, including respiratory and herpes-family viruses; and cell-based products including tubes, blister bottles and multiwell plates. In addition, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the assessment of bone resorption/formation; and enzyme immunoassays and reagents for the detection of activation products. Additionally, it offers Lyra real-time molecular polymerase chain reaction assays; Solana, an amplification and detection system; Savanna, an automated in vitro molecular diagnostic platform; and Virena, a wireless cellular data management and monitoring system. The company markets its products through distributors and a direct sales force for use in medical offices, hospitals, clinical laboratories, reference laboratories, universities, retail and healthcare clinics. emergency rooms, pharmacies and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
About Alpha Teknova (Get a rating)
Alpha Teknova, Inc. provides critical reagents for the life sciences market in the United States and internationally. Its reagents enable the discovery, development and production of biopharmaceuticals, such as drug therapies, new vaccines and molecular diagnostics. The company offers pre-cast media plates for cell growth and cloning; liquid cell culture media and cell expansion supplements; and molecular biology reagents for sample manipulation, resuspension and purification. It serves the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutes. The company was founded in 1996 and is based in Hollister, California.
Get news and reviews for Quidel Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Quidel and related companies with MarketBeat.com’s free daily email newsletter.